Olga Kuczkiewicz-Siemion

Institute of Hematology and Transfusion Medicine

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Malgorzata Debowska

Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences

POLAND

View details

Agnieszka Jagiello-Gruszfeld

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Agnieszka Dansonka-Mieszkowska

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Olga Kuczkiewicz-Siemion

Research Interests

Explore related searches

Contact this professor

Articles (8)

Urothelial carcinoma metastasis to the appendix as the first manifestation of dissemination after radical cystectomy: A case report

Cribriform adenocarcinoma of minor salivary glands presented as a nasopharyngeal tumor: A case report highlighting the significance of cytology

PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters

Small Biopsy Samples: Are They Representative for Biphenotypic Sinonasal Sarcoma?

The Role of Pathology-Based Methods in Qualitative and Quantitative Approaches to Cancer Immunotherapy

The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas – an important diagnostic pitfall

Unique gastrointestinal stromal tumor with PDGFRA D842Y mutation—evaluation of in vivo sensitivity to imatinib

PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma.

Collaborators (3)

Malgorzata Debowska

Agnieszka Jagiello-Gruszfeld

Agnieszka Dansonka-Mieszkowska

Make your next move.